Oosthuizen Johannes Jacobus 4
4 · Merck & Co., Inc. · Filed Feb 11, 2025
Insider Transaction Report
Form 4
Oosthuizen Johannes Jacobus
President, U.S. Market
Transactions
- Exercise/Conversion
Common Stock
2025-02-08$87.28/sh+13,002$1,134,815→ 45,609.474 total - Tax Payment
Common Stock
2025-02-08$87.28/sh−6,404$558,941→ 39,205.474 total - Exercise/Conversion
Restricted Stock Unit
2025-02-08−13,002→ 0 totalFrom: 2025-02-08Exp: 2025-02-08→ Common Stock (13,002 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
- [F2]These restricted stock units vested and were distributed as shares of Merck & Co., Inc. common stock in one installment on 2/8/2025. The Reporting Person's Form 3 filed on 3/10/2022 incorrectly reported that these restricted units vested and were to be distributed in three equal installments on 2/8/2023, 2/8/2024, and 2/8/2025.